NDRA
ENDRA Life Sciences Inc
NASDAQ: NDRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$4.87
+0.41% today
Updated 2026-04-30
Market cap
$5.98M
P/E ratio
—
P/S ratio
1,838.78x
EPS (TTM)
$-8.93
Dividend yield
—
52W range
$3 – $12
Volume
0.1M
ENDRA Life Sciences Inc (NDRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-291.60%
ROA
-86.70%
Debt/equity
3.07x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $559355.00 | $-2.18M | 53.67% | -272.85% | -389.89% |
| 2015 | $1.41M | $-2.28M | 52.75% | -111.24% | -161.64% |
| 2016 | $515582.00 | $-2.78M | 54.25% | -347.52% | -538.30% |
| 2017 | $351622.00 | $-5.38M | 50.86% | -1,315.63% | -1,529.19% |
| 2018 | $6174.00 | $-9.80M | 100.00% | -146,080.47% | -158,669.60% |
| 2019 | $0.00 | $-13.31M | — | — | — |
| 2020 | $0.00 | $-11.73M | — | — | — |
| 2021 | $0.00 | $-11.23M | — | — | — |
| 2022 | $0.00 | $-13.18M | — | — | — |
| 2023 | $0.00 | $-10.06M | — | — | — |
| 2024 | $0.00 | $-11.51M | — | — | — |
| 2025 | $0.00 | $-7.03M | — | — | — |